Nature de la demande
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
rpzLLt9Ef6sPpQhy
